Remote working in the life sciences industry
How to ensure post-lockdown success
29th July 2020
Ninety percent of patients surveyed globally reported that quality of care was as good or better than prior in-person care
21st July 2020
Gary Hughes explains why we’re witnessing a complete transformation of the clinical trial process in the wake of COVID-19
14th July 2020
Why cancer care technology must support both clinicians and patients
14th July 2020
The value of pre-existing collaboration in COVID-19 clinical trials
8th July 2020
David Peacock, MSD UK’s managing director, shares his thoughts on why companies should enter the Patient Partnership Index
2nd July 2020
A look at some of pharma's approaches to addressing the potentially deadly hyperinflammation seen in some patients with COVID-19
25th June 2020
If COVID-19 has taught us anything, it’s that we need speed and accuracy now, and digitalisation could help
24th June 2020
COVID-19 has disrupted clinical trial activity but has simultaneously unleashed a flurry of new innovations that will continue to drive growth in the field, says Murray Aitken
15th June 2020
Healthcare staffing in a pandemic: the role of big data, analytics, cloud computing and visualisation
11th June 2020
The importance of the UK building a domestic pharmaceutical and vaccine manufacturing sector, both in the context of COVID-19 and exiting the EU
9th June 2020
Neurodivergent individuals are systematically overlooked in recruitment processes but are a talent pool that could be highly valuable to the pharma sector, says Marita Hazeldene
26th May 2020
Brendan Shaw says COVID-19 has tested fragility and resilience in our health systems - and we have failed
15th May 2020
Victoria Langdon says it's time for big pharma to step up…or risk losing out to big tech
14th May 2020
Accenture's Brad Michel considers how life sciences companies can begin to re-open as we tentatively move to easing lockdown restrictions
13th May 2020